FTSE Rallies Amidst Oil And Yield Surge

London's FTSE 100 rose on Monday as investors flocked to defensive sectors, including healthcare and consumer staples, while energy majors gained tracking a fresh surge in crude prices. The benchmark index pushed higher following a week of heavy losses, balancing rising Gilt yields against global market anxiety ahead of major central bank rate decisions.

Defensive sectors led broad-based gains. Pharmaceuticals saw strong buying interest, advancing 2.7%, headlined by GSK which jumped 3.7% after announcing positive clinical results for two lung cancer treatments, Jideytro and Ris-Rez. Personal care, drug, and grocery shares gained 2.6%, while beverages added 2.8%. Energy heavyweights BP and Shell (SHEL) rose 1.1% each as Brent crude climbed roughly 3% following renewed strikes on Saudi infrastructure and Gulf shipping. Conversely, industrial and precious metal miners were the day's main percentage laggards, dragged down by falling underlying metal prices.

Technology stocks presented a stark regional contrast. Futures tied to the U.S. Nasdaq slipped 1.8% after chief executives of prominent AI laboratories, including OpenAI and Anthropic, publicly called for a slower pace of AI development, dragging down international tech sentiment. However, the FTSE 350 tech sector bucked the global trend, climbing 3.9%.

On the macro and political stage, central bank decisions dominate the week's horizon. The Federal Reserve is set to announce its interest rate path on Wednesday, with money markets pricing an 88.5% probability of a 25-basis-point rate hike according to CME's FedWatch Tool. Domestically, investors await key UK employment and inflation releases ahead of the Bank of England’s decision on Thursday, where policymakers are widely expected to keep interest rates unchanged. Meanwhile, Prime Minister Andy Burnham met with senior leaders from major banks, oil companies, and telecommunications firms on Monday to outline his domestic economic growth strategy.

Finish Line: U.K. equities found firm footing to start the week as pharmaceutical breakthroughs, consumer defensives, and rising crude oil offset broader global tech anxieties and elevated bond yields. With crucial domestic inflation data and central bank policy decisions from both the Fed and the BoE looming, the FTSE 100 relies on its defensive heavyweights to maintain momentum.

TECHNICAL & TRADE VIEW – FTSE100